Page 3123 - Markets News

Sensex breaks four-session fall on value buying

Major gainers were HUL 1.37%, HDFC with 1.25% and Tata Motors with 1.06%

Escorts: Strong second half ahead

Higher demand and product launches should drive volumes & market share

Benign liquidity situation to support markets: Kalpen Parekh

Parekh says investors should temper their return expectations as interest rates have fallen over the past three years and valuations have stretched considerably

DLF: Reducing balance sheet stress

After deleveraging, the Street will watch out for the pace of inventory sale

Analysts bet on EPC firms in road infra

Players with a strong balance sheet, execution track record, and robust asset portfolio would be key beneficiaries

NSE may refile IPO papers after getting clarity on algo-trading case

NSE's IPO is being keenly awaited in the market as one of the biggest in recent times

Markets end volatile day flat, Nifty dips below 10150 ahead of RBI policy

All that happened in today's trade

63 Moons hits lower circuit after Bombay High Court rejects writ petition

The stock locked in lower circuit of 5% at Rs 131, down 7% from intra-day high on the BSE.

Auto ancillary shares in focus; Fiem Ind, SSWL, Steco Automotive up over 5%

Setco Automotive hit a 52-week high of Rs 48.40, up 15% on the BSE in intra-day trade after the company reported a standalone net profit of Rs 13.76 crore in Q2 against loss of Rs 11.89 crore in Q1.

KNR Constructions, Sadbhav Engineering among road infra space's top picks

As EPC remains preferred bet, analysts' top picks include KNR Constructions, Sadbhav Engineering, and PNC Infratech, among others

Jubilant Life Sciences up 5% on talk of green panel for pesticide project

The stock of an integrated global pharmaceutical and life sciences company has rallied 14% in past three trading sessions.

Infosys rally likely to be short-lived; tender shares in buyback: analysts

Another reason, analysts say, why the cheer may just be short-lived is the buyback offer. For Infosys to get back the trust of long-term investors, they will have to enunciate a business strategy soon

Lupin, Glenmark Pharma hit 52-week lows

In past one month, the market price of Lupin has fallen 23%, while of Glenmark Pharma by 12% against 2% decline in the S&P BSE Sensex.

Biocon surges 14% on USFDA approval for biosimilar of cancer drug Herceptin

The stock surged 14% to Rs 510, also its all-time high on the BSE in early morning trade on back of heavy volumes.

Support for Nifty is seen at 9950, resistance at 10280: Prabhudas Lilladher

Nifty Outlook And Key Trading Ideas By Vaishali Parekh, Research Analyst - Technical Research At Prabhudas Lilladher

Co-location case: Probe gathers steam; SFIO may be roped in

The case relates to some brokers allegedly getting preferential access through co-location facility at the NSE, early login and dark fibre.

Street continues to be wary of PSBs

Lingering concerns over asset quality and lack of clarity on a capital infusion plan are seen as the reasons

Crude oil casts a shadow on Dalal Street

In the past, every major market correction has been preceded by higher crude oil prices and vice versa

Street signs: LIC pares holdings in PSBs

Shares of Religare Enterprises have gained 40% in the past fortnight after the financial services firm announced major changes to its board and management

India not in core portfolio, but would add on a dip: Mark Matthews

India is a good market to buy and hold, says Mark Matthews of Julius Baer Group